Arcturus Therapeutics (ARCT) News Today → [BUY ALERT] Our #1 A.I. Stock for March (From Behind the Markets) (Ad) Free ARCT Stock Alerts $33.77 +0.91 (+2.77%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells $610,573.70 in Stockinsidertrades.com - March 28 at 8:25 AMARK Investment Management LLC Acquires 146,141 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 28 at 6:39 AMArcturus Therapeutics Holdings Inc (ARCT) Insider Sells Sharesfinance.yahoo.com - March 28 at 2:28 AMInsider Selling: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells 17,435 Shares of Stockmarketbeat.com - March 27 at 6:40 PMOptimistic Buy Rating for Arcturus Therapeutics Amid Strong Kostaive Vaccine Market Prospects in Japanmarkets.businessinsider.com - March 27 at 10:10 AMArcturus Therapeutics (NASDAQ:ARCT) Trading Down 6.5%marketbeat.com - March 26 at 4:22 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Recommendation of "Buy" from Analystsamericanbankingnews.com - March 25 at 3:32 AMPad Chivukula Sells 8,565 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Stockamericanbankingnews.com - March 23 at 5:38 AMInsider Selling: Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells 8,565 Shares of Stockinsidertrades.com - March 22 at 10:02 AMArcturus Therapeutics Holdings Inc's Chief Scientific Officer & COO Pad Chivukula Sells ...finance.yahoo.com - March 22 at 2:11 AMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Sells $299,860.65 in Stockmarketbeat.com - March 21 at 7:57 PMArcturus Therapeutics (NASDAQ:ARCT) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - March 21 at 4:20 AMArcturus Therapeutics' (ARCT) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - March 20 at 8:11 AMArcturus Therapeutics (NASDAQ:ARCT) Shares Up 3%marketbeat.com - March 19 at 11:59 AMArcturus Therapeutics (NASDAQ:ARCT) Stock Price Down 5.3%marketbeat.com - March 18 at 12:44 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Short Interest Down 6.6% in Februarymarketbeat.com - March 18 at 11:24 AMArcturus Therapeutics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lagfinance.yahoo.com - March 17 at 2:09 PMARCT Apr 2024 30.000 callca.finance.yahoo.com - March 16 at 9:56 AMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Purchased by AQR Capital Management LLCmarketbeat.com - March 13 at 4:33 AMThe Analyst Verdict: Arcturus Therapeutics In The Eyes Of 4 Expertsmarkets.businessinsider.com - March 11 at 12:01 PMAnalysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)markets.businessinsider.com - March 11 at 6:59 AMArcturus Therapeutics Holdings Inc. (ARCT) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 9 at 8:35 PMAnalysts Offer Insights on Healthcare Companies: Cigna (CI) and Arcturus Therapeutics (ARCT)markets.businessinsider.com - March 8 at 1:29 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 8 at 1:29 PMWilliam Blair Reiterates Outperform Rating for Arcturus Therapeutics (NASDAQ:ARCT)marketbeat.com - March 8 at 11:23 AMQ4 2023 Arcturus Therapeutics Holdings Inc Earnings Callfinance.yahoo.com - March 8 at 8:29 AMQube Research & Technologies Ltd Has $3.97 Million Stock Holdings in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 8 at 5:43 AMArcturus Therapeutics Reports Fiscal Year 2023 Financial Results and Pipeline Developmentsfinance.yahoo.com - March 8 at 1:45 AMARCT Stock Earnings: Arcturus Therapeutics Beats EPS, Misses Revenue for Q4 2023investorplace.com - March 7 at 11:06 PMRecap: Arcturus Therapeutics Q4 Earningsbenzinga.com - March 7 at 8:45 PMArcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2023 Financial Update and Pipeline Progressbusinesswire.com - March 7 at 4:01 PMARCT Sep 2024 30.000 putfinance.yahoo.com - March 7 at 10:44 AMSchonfeld Strategic Advisors LLC Makes New Investment in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - March 7 at 6:40 AMEarnings Preview: Arcturus Therapeuticsbenzinga.com - March 6 at 6:26 PMHere's what Wall Street expects from Arcturus Therapeutics's earningsmarkets.businessinsider.com - March 6 at 6:26 PMArcturus Therapeutics Q4 2023 Earnings Previewmsn.com - March 6 at 6:26 PMArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Shares Purchased by Fmr LLCmarketbeat.com - March 5 at 5:58 AMArcturus Therapeutics Holdings Inc (ARCT)investing.com - March 2 at 1:12 PMArcturus Therapeutics (NASDAQ:ARCT) Sets New 1-Year High at $42.64marketbeat.com - February 27 at 10:43 AM7 Under-the-Radar Biotech Stocks Gearing Up for Liftoffinvestorplace.com - February 26 at 3:20 PMArcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conferencefinance.yahoo.com - February 26 at 1:17 PMArcturus Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conferencebusinesswire.com - February 26 at 9:00 AMArcturus Therapeutics Receives Orphan Medicinal Product Designation from the European Commission (EC), for ARCT-032, for the Treatment of Cystic Fibrosisbusinesswire.com - February 22 at 8:30 AMFederated Hermes Inc. Has $120.38 Million Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - February 21 at 5:07 PMWall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for February 2024investorplace.com - February 21 at 1:04 PM3 Tech Stocks That Could Be Multibaggers in the Making: February Editioninvestorplace.com - February 20 at 4:39 PMARCT Jun 2024 22.500 callca.finance.yahoo.com - February 20 at 3:31 PMArcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024finance.yahoo.com - February 20 at 10:30 AMArcturus Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on March 7, 2024businesswire.com - February 20 at 9:00 AMBlair William & Co. IL Acquires Shares of 18,705 Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)marketbeat.com - February 20 at 5:50 AM Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address [BUY ALERT] Our #1 A.I. Stock for March (Ad)It's the one AI stock nobody is talking about. Cathy Wood just bought 11 million shares of it. Get the name of the stock here - before it takes off >>> ARCT Media Mentions By Week ARCT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARCT News Sentiment▼0.820.61▲Average Medical News Sentiment ARCT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARCT Articles This Week▼123▲ARCT Articles Average Week Get Arcturus Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ARCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Astria Therapeutics News Innoviva News ABIVAX Société Anonyme News Pliant Therapeutics News ARS Pharmaceuticals News Arcutis Biotherapeutics News ORIC Pharmaceuticals News MacroGenics News Tango Therapeutics News Zentalis Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARCT) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry ResearchAI healthcare stock poised for 36,996% growth?Behind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcturus Therapeutics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.